Baltic Atherosclerosis Conference 2020

The programme of the Congress should help practitioners to find answers to the questions they are facing in their daily work. Our activities are focused on clinically oriented primary and secondary prevention. The programme will tackle all the major risk factors and mechanisms of atherosclerosis as usually, with special emphasis on lipid management in secondary prevention of cardiovascular disease, familial dyslipidemias such as familial hypercholesterolemia and cardiovascular risk in diabetes.

Despite the recent advances in the cardiovascular prevention and atherosclerosis research, the burden of the cardiovascular morbidity and mortality remains very high in all the three Baltic countries. This will give the opportunity to bring together state-of-art research in the field of atherosclerosis and create strong forum for exchanging ideas and seeking solutions for the future.

For registered delegates, who can not gather on-site, we will open virtual window to follow conference live stream and invite them to participate via interactive app with Q/A sessions and networking possibility. All delegates have possibility to interact with conference exhibitors via special conference expo-room, learn about their new products and technical solutions.
Virtual (on-line) participation at BAS 2020 is free for pre-registered delegates (medical specialists, doctors, nurses and residents). A small fee is charged from on-site participants to cover some of the costs of our event. 

BALTIC ATHEROSCLEROSIS SOCIETY HYBRID CONFERENCE SCIENTIFIC PROGRAM „DYSLIPIDEMIA AND DIABETES MANAGEMENT TO PREVENT ATHEROSCLEROSIS“

09:00-09:30   On-site registration. Virtual arrival (relevant url and information e-mail will be sent to registered users 3 days before the beginning of the conference)

09:30              Opening of the conference

09:40-11:00 I session „Emerging topics in atherosclerosis diagnostics and management“:

Chairmen: Andrejs Erglis (Riga), Anu Hedman (Tallinn), Sergei Nazarenko (Tallinn)

09:40-10:05  Emerging risk biomarkers in cardiovascular diseases. Dovilė Karčiauskaitė (Vilnius)

10:05-10:15   Genetic testing of familial hypercholesterolemia. Kairit Joost (Tallinn)

10:15-10:40   Lifestyle is the cornerstone of cardiovascular prevention. Iveta Mintale (Riga)

10:40-11:05  Anticoagulants in the prevention of atherothrombotic events. Kristina Lotamõis (Tallinn)

11:05-11:15   Discussion

11:15-11:30   Coffee, exhibition

11:30-13:30 II session „Update of the management of dyslipidemia“:

Chairmen: Gustavs Latkovskis (Riga), Žaneta Petrulionienė (Vilnius), Margus Viigimaa (Tallinn)

Challenges of the management of familial hypercholesterolemia in the light of the new lipid guidelines. Gustavs Latkovskis (Riga)

Treatment efficacy of FH based on the Norwegian FH registry. Martin Prøven Bogsrud (Oslo)

Experience of dyslipidemia treatment in Finland. Katriina Aalto-Setälä (Tampere)

Aggressive treatment of dyslipidemia in secondary prevention of cardiovascular disease. Margus Viigimaa (Tallinn)

13:30 -14:30  Lunch, exhibition

14:30-16:00 III session „Novel cardioprotective treatment of diabetes“: 

Chairmen: Valdis Pirags (Riga), Rimvydas Šlapikas (Kaunas), Margus Viigimaa (Tallinn)

14.30-15:00   Reducing CV death in patients with type 2 diabetes. Gustavs Latkovskis (Riga)

15:00-15:30   Reducing HF hospitalisation in patients with type 2 diabetes. Pentti Põder (Tallinn)

15:30-16:00   Reducing CKD in patients with type 2 diabetes. Marius Miglinas (Vilnius)

16:00-16:15   Concluding remarks. Margus Viigimaa (Tallinn), Martin Serg (Tallinn)

16:15              Say Goodbye Coffee

CONTACT INFORMATION:

More information You can find here

Registration to the conference is open HERE

If you have questions or you need additional information about the event, please contact Conference Secretariat

Conference Expert / Reisieksperdi AS

Roosikrantsi 8B, Tallinn, Estonia R

egistration no 10101104

Kadri Jõerüüt, Member of Board, phone +372 6108 641